Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M179Revenue $M243Net Margin (%)-18.5Altman Z-Score-0.1
Enterprise Value $M361EPS $-1.6Operating Margin %-6.8Piotroski F-Score5
P/E(ttm)--Beneish M-Score14.0Pre-tax Margin (%)-18.0Higher ROA y-yY
Price/Book1.310-y EBITDA Growth Rate %--Quick Ratio1.7Cash flow > EarningsY
Price/Sales0.75-y EBITDA Growth Rate %-19.1Current Ratio2.4Lower Leverage y-yY
Price/Free Cash Flow5.7y-y EBITDA Growth Rate %--ROA % (ttm)-10.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-29.1Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M28.9ROIC % (ttm)-8.5Gross Margin Increase y-yN

Gurus Latest Trades with AEGR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AEGRMichael Price 2014-12-31 Sold Out -1%$19.66 - $35.02
($25.02)
$ 6.18-75%Sold Out0
AEGRGeorge Soros 2014-12-31 Sold Out -0.01%$19.66 - $35.02
($25.02)
$ 6.18-75%Sold Out0
AEGRJoel Greenblatt 2014-12-31 Sold Out $19.66 - $35.02
($25.02)
$ 6.18-75%Sold Out0
AEGRGeorge Soros 2014-09-30 Buy 0.01%$26.93 - $35.65
($30.96)
$ 6.18-80%New holding25,000
AEGRJoel Greenblatt 2014-09-30 Buy $26.93 - $35.65
($30.96)
$ 6.18-80%New holding10,964
AEGRMichael Price 2014-03-31 Buy 1.1%$43.65 - $73.75
($59.26)
$ 6.18-90%New holding200,000
AEGRGeorge Soros 2012-06-30 Sold Out -0.01%$11.76 - $16.96
($14.02)
$ 6.18-56%Sold Out0
AEGRGeorge Soros 2011-06-30 Buy 0.01%$15.29 - $21.85
($17.62)
$ 6.18-65%New holding37,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AEGR is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AEGR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Broadfin Healthcare Master Fun10% Owner 2015-11-11Buy40,100$10.96-43.61view
Fitzpatrick Mark J.CFO 2014-08-19Buy1,150$30.64-79.83view
Beer Marc DCEO 2014-07-31Buy10,000$33.65-81.63view
Beer Marc DCEO 2014-06-03Buy10,000$30.12-79.48view
Beer Marc DCEO 2014-05-27Buy10,000$31.59-80.44view
Beer Marc DCEO 2014-05-20Buy10,000$30.53-79.76view
Beer Marc DCEO 2014-05-08Buy30,000$35.31-82.5view
VANLENT ANNEDirector 2014-05-08Buy4,000$33.78-81.71view
Fraser CraigPres., US/Int. Comm. & Manuf. 2014-04-30Sell2,250$43.55-85.81view
Fraser CraigPres., US/Int. Comm. & Manuf. 2014-03-31Sell2,250$46.2-86.62view

Quarterly/Annual Reports about AEGR:

News about AEGR:

Articles On GuruFocus.com
Gilead Sciences Releases Impressive Results for Hepatitis C Drug Nov 12 2014 
Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 
Weekly CEO Buys Highlight: GEO, TRUE, BANC, AEGR, CLMS Jun 02 2014 
Three CEOs Reporting Large Insider Buys May 22 2014 
Four CEOs Reporting Large Insider Buys May 09 2014 
100 Stocks at All-Time Highs | 60 Dividend Stocks Below the Results Feb 19 2013 
My 3 Favorite Dividend Stocks at All-Time-Highs | Stock List Dec 27 2012 
Weekly CFO Buys Highlight: RXN, XBKS, STAG, AEGR, PZG Apr 02 2012 

More From Other Websites
AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities Feb 11 2016
7:05 am Aegerion Pharma is reducing ~25% percent of its global workforce by end of 2Q16 Feb 11 2016
Aegerion Pharmaceuticals Announces Reduction in Workforce as Part of Cost Reduction Plan Feb 11 2016
Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program Feb 10 2016
Aegerion Pharmaceuticals Announces Presentation at the Leerink Partners Global Healthcare Conference Feb 04 2016
AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Feb 03 2016
[$$] Six Biotechs to Like Right Now Jan 25 2016
5 Stocks Under $10 Set to Soar Jan 21 2016
Aegerion Provides Preliminary Sales View & Pipeline Updates Jan 12 2016
Aegerion Pharmaceuticals Reports Preliminary 2015 Net Product Sales and Other Business Updates Jan 11 2016
AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 11 2016
Aegerion Pharmaceuticals Reports Preliminary 2015 Net Product Sales and Other Business Updates Jan 11 2016
Aegerion Pharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference Jan 08 2016
Aegerion Pharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference Jan 08 2016
Aegerion Pharmaceuticals Appoints Mary Szela as Chief Executive Officer Jan 07 2016
Aegerion Pharmaceuticals Appoints Mary Szela as Chief Executive Officer Jan 07 2016
Biotechnology Equities at a Glance -- Chimerix, Vitae Pharma, Aegerion Pharma, and Compugen Jan 05 2016
Why Aegerion Pharmaceuticals (AEGR) Could Beat Earnings Estimates Again Dec 30 2015
Aegerion Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 22 2015
Pharmaceutical And LNG Stocks Are Driving The Market Higher Today Dec 21 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK